A comprehensive GH-axis and fat-metabolism research blend using three complementary peptides.
A stabilised GH lipolytic domain peptide studied for fat-burning activity independent of growth-promoting effects.
A high-volume Retatrutide format offering extended research capacity for metabolic and obesity studies.
A mitochondria-derived peptide studied for metabolic regulation, insulin sensitisation, and exercise mimetic properties.
A triple receptor agonist (GLP-1, GIP, and glucagon) representing one of the most advanced metabolic research peptides available.
A GLP-1 receptor agonist peptide studied extensively for appetite regulation, insulin sensitivity, and metabolic health.
Double-strength Tesamorelin vial for extended GHRH research and high-throughput protocols.
A GHRH analogue studied for stimulating growth hormone release and reducing visceral adipose tissue.